The role of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in ovarian carcinoma: where do we stand today? A comprehensive review and clinical insights from a leading oncology center in India

Abstract Background The current treatment for advanced epithelial ovarian cancer (EOC) is complete cytoreductive surgery (CRS) followed by adjuvant chemotherapy. Although many patients respond well to this treatment, many will relapse and die from peritoneal carcinomatosis. Adding Hyperthermic Intra...

Descripción completa

Detalles Bibliográficos

Autores principales:	M D Ray, Rohan Kapoor, Carolin Solomi, Divyam Goel, Babul Bansal
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2025-06-01
Colección:	World Journal of Surgical Oncology
Materias:	Epithelial Ovarian Cancer Cytoreductive Surgery (CRS) Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Disease-Free Survival Overall Survival Peritoneal Carcinomatosis
Acceso en línea:	https://doi.org/10.1186/s12957-025-03869-0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!